Resistance Training as Treatment of Achilles Tendinopathy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00952042|
Recruitment Status : Completed
First Posted : August 4, 2009
Last Update Posted : July 21, 2014
The use of eccentric resistance training as management of Achilles tendinopathy is widespread. The investigators have recently demonstrated that heavy slow resistance training was superior in the management of patellar tendinopathy.
Hypothesis: heavy slow resistance training is more effective than eccentric resistance training in the clinical management of Achilles tendinopathy.
|Condition or disease||Intervention/treatment||Phase|
|Achilles Tendinopathy||Other: Heavy slow resistance training Other: Eccentric resistance training||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||47 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Heavy Slow Resistance Versus Eccentric Training in the Treatment of Achilles Tendinopathy. A Randomized Controlled Trial.|
|Study Start Date :||July 2009|
|Actual Primary Completion Date :||October 2012|
|Actual Study Completion Date :||October 2012|
Experimental: Heavy slow resistance training
12 wks of heavy slow resistance training. training three times per week. each session: 3 heel-raise exercises. 12-6RM. Slow contractions.
Other: Heavy slow resistance training
Heel-raises. 12-6RM. each contraction performed slowly. three times weekly for 12 weeks
Active Comparator: Eccentric resistance training
12 wks of eccentric resistance training. 3 x 15 Eccentric heel-raises performed twice daily.
Other: Eccentric resistance training
Eccentric heel-raises. 3 x 15 reps performed twice daily for 12 wks.
- VISA-A score [ Time Frame: 0,12 wks + 1yr follow-up ]
- Tendon thickness [ Time Frame: 0,12 wks + 1yr follow-up ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00952042
|Institute of Sports Medicine Copenhagen. Bispebjerg Hospital|
|Copenhagen NV, Denmark, 2400|
|Principal Investigator:||Rikke Beyer, PhD. stud||Institute of Sports Medicine Copenhagen (www.ismc.dk)|